Akebia Therapeutics Ownership | Who Owns Akebia Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Akebia Therapeutics Ownership Summary

Akebia Therapeutics is owned by 9.89% institutional investors, 4.01% insiders, and 86.11% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.27% of AKBA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in Akebia Therapeutics shares.

AKBA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akebia Therapeutics	9.89%	4.01%	86.11%
Sector	Healthcare Stocks	35.74%	11.83%	52.43%
Industry	Biotech Stocks	36.05%	11.82%	52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	18.69M	7.27%	$25.98M
Vanguard group	16.02M	6.05%	$25.79M
Blackrock	11.64M	5.68%	$11.87M
State street	11.61M	4.52%	$16.14M
Alerce investment management	5.75M	2.73%	$10.92M
Geode capital management	6.45M	2.51%	$8.97M
Goldman sachs group	3.60M	1.40%	$5.01M
Citigroup	2.85M	1.11%	$3.97M
Bioimpact capital	2.89M	1.10%	$7.89M
Qube research	2.40M	0.93%	$3.33M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alerce investment management	5.75M	19.23%	$10.92M
Bioimpact capital	2.89M	1.29%	$7.89M
Virtus etf advisers	308.00K	0.20%	$428.12K
Nantahala capital management	2.00M	0.10%	$2.78M
Entrypoint capital	201.75K	0.08%	$280.43K
Orchard capital management	53.51K	0.08%	$74.38K
Mangrove partners	375.95K	0.04%	$522.58K
Sherbrooke park advisers	28.39K	0.04%	$77.50K
Round rock advisors	166.09K	0.04%	$230.86K
Alphamark advisors	38.46K	0.03%	$73.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	11.64M	0.00%	9.10M
Vanguard fiduciary trust	1.78M	0.00%	1.78M
Two sigma investments, lp	1.30M	0.00%	1.21M
Aqr capital management	1.79M	0.00%	1.15M
Jane street group	1.46M	0.00%	765.09K

Top Sellers

Holder	Shares	% Assets	Change
Citadel advisors	1.39M	0.00%	-3.28M
Aigh capital management	-	-	-2.92M
Affinity asset advisors	-	-	-2.45M
State street	11.61M	0.00%	-2.07M
Great point partners	-	-	-1.99M

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	1.78M	0.00%	1.78M	$2.47M
Mangrove partners	375.95K	0.04%	375.95K	$522.58K
Jump financial	355.84K	0.01%	355.84K	$971.45K
Virtus etf advisers	308.00K	0.20%	308.00K	$428.12K
Freestone grove partners lp	202.12K	0.00%	202.12K	$551.79K

Sold Out

Holder	Change
Stephens consulting	-6.00
Pnc financial services group	-13.00
Ifp advisors	-52.00
Capital performance advisors llp	-68.00
Hexagon capital partners	-186.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	74	-57.47%	25,424,603	-78.55%	9	0.49%	36	-57.65%	16	-68.63%
Dec 31, 2025	111	-39.01%	92,263,820	-25.41%	34	1.57%	48	-56.36%	35	-2.78%
Sep 30, 2025	172	12.42%	122,932,544	28.32%	46	2.83%	102	-3.77%	34	54.55%
Jun 30, 2025	162	8.72%	108,281,334	13.45%	45	2.80%	111	19.35%	23	-11.54%
Mar 31, 2025	150	19.05%	95,500,610	40.77%	40	3.90%	94	34.29%	27	22.73%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	7.91M	2.95%	-
Vanguard US Total Market Shares ETF	5.95M	2.52%	-
State Street® SPDR® S&P® Biotech ETF	6.56M	2.45%	-67.78K
iShares Russell 2000 ETF	6.00M	2.24%	50.57K
SPDR® S&P Biotech ETF	3.09M	1.17%	6.91K
Vanguard Institutional Extnd Mkt Idx Tr	3.00M	1.12%	19.21K
Fidelity Small Cap Index	2.46M	0.92%	10.30K
iShares Russell 2000 Value ETF	1.97M	0.74%	10.62K
Foord Global Equity (Lux) A	1.96M	0.73%	1.96M
Foord Global Equity Class B	1.83M	0.68%	1.83M

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2026	Butler John P.	CEO and President	Buy	$86.59K
Feb 02, 2026	Malabre Richard C	SVP, Chief Accounting Officer	Sell	$50.24K
Feb 02, 2026	Malabre Richard C	SVP, Chief Accounting Officer	Sell	$18.60K
Feb 02, 2026	Grund Nicholas	Chief Commercial Officer	Sell	$43.43K
Feb 02, 2026	Grund Nicholas	Chief Commercial Officer	Sell	$74.48K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	1	15
2025 Q2	-	3
2025 Q1	-	8
2024 Q2	-	2

AKBA Ownership FAQ

Who Owns Akebia Therapeutics?

Akebia Therapeutics shareholders are primarily institutional investors at 9.89%, followed by 4.01% insiders and 86.10% retail investors. The average institutional ownership in Akebia Therapeutics's industry, Biotech Stocks , is 36.05%, which Akebia Therapeutics falls below.

Who owns the most shares of Akebia Therapeutics?

Akebia Therapeutics’s largest shareholders are Blackrock funding, inc. /de (18.69M shares, 7.27%), Vanguard group (16.02M shares, 6.05%), and Blackrock (11.64M shares, 5.68%). Together, they hold 19.00% of Akebia Therapeutics’s total shares outstanding.

Does Blackrock own Akebia Therapeutics?

Yes, BlackRock owns 5.68% of Akebia Therapeutics, totaling 11.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.87M$. In the last quarter, BlackRock increased its holdings by 9.1M shares, a 358.35% change.

Who is Akebia Therapeutics’s biggest shareholder by percentage of total assets invested?

Alerce investment management is Akebia Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.23% of its assets in 5.75M Akebia Therapeutics shares, valued at 10.92M$.

Who is the top mutual fund holder of Akebia Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Akebia Therapeutics shares, with 2.95% of its total shares outstanding invested in 7.91M Akebia Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools